🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
This phase II trail will evaluate the efficacy and safety of combining gemc...
Status
Recruiting
Location
Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University
Start Date
2024-10-24
Trial ID
NCT06591650
Treatments Being Tested
This is a phase 3 study. All subjects are patients with unresectable locall...
Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2024-10-20
Trial ID
NCT06591520
Treatments Being Tested
Underlying disease mechanisms are fundamental for correct treatment selecti...
Status
Unknown
Location
Department of Radiology, IRCCS Ospedale San Raffaele
Start Date
2024-05-01
Trial ID
NCT06375915
Treatments Being Tested
The purpose of this study is to measure the efficacy and safety of rilvegos...
Status
Recruiting
Location
Research Site
Start Date
2025-12-04
Trial ID
NCT07221253
Treatments Being Tested
This study is being done to see if the investigators can improve the outcom...
Status
Recruiting
Location
Maryland Proton Treatment Center
Start Date
2024-10-29
Trial ID
NCT06546969
Treatments Being Tested
Durvalumab and Tremelimumab in combination with first-line chemotherapy in ...
Status
Completed
Location
Research Site
Start Date
2016-04-28
Trial ID
NCT02658214
Treatments Being Tested
This is a randomized, open-label, multi-center, global, Phase III study to ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-06-01
Trial ID
NCT03164616
Neoadjuvant chemo- and immunotherapy ameliorate the recurrence rate of chol...
Status
Recruiting
Location
Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale
Start Date
2023-09-01
Trial ID
NCT06341764
This phase II trial tests how well giving gemcitabine, cisplatin and durval...
Status
Not Yet Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2026-11-01
Trial ID
NCT07780838